Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and genetic association of comorbid provisional PMDD and ADHD in female patients with bipolar disorder.

Journal of affective disorders·2026
Same author

Genome-wide association study and polygenic risk score analysis for bipolar disorder in the Korean population.

Asian journal of psychiatry·2026
Same author

Editorial: Mental health in the age of artificial intelligence.

Frontiers in psychiatry·2026
Same author

Deep Phenotyping at Scale: Study Protocol for the Korean Mood Disorder Genetic Study-Depression (KOMOGEN-D).

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2025
Same author

Defining Treatment-Resistant Bipolar Depression: Recommendations From the ISBD Task Force.

Bipolar disorders·2025
Same author

Sports Facility Use and Perceptions of Exercise Effectiveness: A Nationwide Survey of People with Disabilities in South Korea.

Healthcare (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 28, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Management of bipolar depression.

Jae Seung Chang1, Kyooseob Ha

  • 1Department of Psychiatry and Behavioral Neuroscience, Seoul National University College of Medicine, Seoul, South Korea.

Indian Journal of Psychological Medicine
|October 25, 2011
PubMed
Summary

Bipolar depression is often misdiagnosed and undertreated. This review highlights lithium, valproate, lamotrigine, quetiapine, and olanzapine as effective treatments, emphasizing combined therapy for better outcomes.

Keywords:
Anticonvulsantsantidepressantsbipolar depressionlithiumpsychosocial interventionsecond-generation antipsychotics

Related Experiment Videos

Last Updated: May 28, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • Bipolar disorder predominantly involves depressive episodes, often misdiagnosed and inadequately treated.
  • Existing treatments for bipolar depression show limited efficacy for acute and residual symptoms.

Purpose of the Study:

  • To review current treatment strategies for bipolar depression.
  • To summarize evidence for pharmacotherapy and psychosocial interventions.

Main Methods:

  • Literature review of clinical trials and guidelines.
  • Analysis of treatment efficacy for acute and prophylactic management.

Main Results:

  • Lithium demonstrates antidepressive and antisuicidal effects.
  • Valproate and lamotrigine are potential first-line options.
  • Quetiapine and olanzapine show promise for bipolar depression.
  • Antidepressant use is controversial; combination with mood stabilizers is recommended.
  • Psychosocial interventions show promise when integrated with pharmacotherapy.

Conclusions:

  • Individualized, combined treatment strategies are essential for managing bipolar depression.
  • Further research is needed on existing agents and psychosocial interventions.